It seems like Cryobanks has so much potential. If we are having trouble meeting the Biostem merger requirements, why don't we go somewhere else. There must be other shell opportunities. Something does not smell right if someone keeps delaying the financing deal. Why and for what purpose. Don't forget that there was bridge financing in place. That short term financing must have been regoitated, too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.